Renal involvement in preeclampsia: similarities to VEGF ablation therapy (Q34735646)

4 August 2017

9 references

13 March 2019

19 June 2019

31 July 2019

28 September 2019

9 October 2019

20 November 2019

15 December 2019

20 August 2020

5 November 2020

Renal involvement in preeclampsia: similarities to VEGF ablation therapy (English)

1 reference

vascular endothelial growth factor A

4 August 2017

9 references

13 March 2019

19 June 2019

31 July 2019

28 September 2019

9 October 2019

20 November 2019

15 December 2019

20 August 2020

5 November 2020

cell surface receptor

1 reference

31 July 2019

1 reference

28 September 2019

1 reference

9 October 2019

1 reference

20 November 2019

1 reference

15 December 2019

1 reference

vascular endothelial growth factor receptor 1 (VEGFR1)

20 August 2020

1 reference

20 August 2020

angiogenesis inhibitor

1 reference

5 November 2020

1

Janina Müller-Deile

0 references

Mario Schiffer

object named as

Mario Schiffer

series ordinal

2

0 references

publication date

23 December 2010

10 references

4 August 2017

13 March 2019

19 June 2019

31 July 2019

28 September 2019

9 October 2019

20 November 2019

15 December 2019

20 August 2020

5 November 2020

10 references

4 August 2017

13 March 2019

19 June 2019

31 July 2019

28 September 2019

9 October 2019

20 November 2019

15 December 2019

20 August 2020

5 November 2020

2011

1 reference

4 August 2017

page(s)

176973

1 reference

Creative Commons Attribution 3.0 Unported

4 August 2017

copyright license

9 references

13 March 2019

19 June 2019

31 July 2019

28 September 2019

9 October 2019

20 November 2019

15 December 2019

20 August 2020

on focus list of Wikimedia project

5 November 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

The balance of autocrine VEGF-A and VEGF-C determines podocyte survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Renal effects of anti-angiogenesis therapy: update for the internist

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

VEGF inhibition and renal thrombotic microangiopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Nephrotic syndrome after bevacizumab: case report and literature review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Chronic active thrombotic microangiopathy in native and transplanted kidneys

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Soluble endoglin contributes to the pathogenesis of preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Managing patients treated with bevacizumab combination therapy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Preeclampsia: a renal perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

VEGF(165) mediates glomerular endothelial repair

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

The Hellp syndrome: is this a clinical form of thrombotic microangiopathy?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066648

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.

7 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Urinary podocyte excretion as a marker for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Exaggerated hypotensive effect of vascular endothelial growth factor in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F176973

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

21 January 2018

1 reference

12 December 2020

Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney

1 reference

12 December 2020

Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link?

1 reference

12 December 2020

Thrombotic microangiopathy and anti-VEGF agents

1 reference

12 December 2020

Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition

1 reference

12 December 2020

Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier

1 reference

12 December 2020

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia

1 reference

12 December 2020

Acute and transient podocyte loss and proteinuria in preeclampsia

1 reference

12 December 2020

[Anti-vascular endothelial growth factor (VEGF) therapy: a new cause of secondary hypertension]

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/176973

1 reference

release_guo6zxblnbgqffnmsupvlidyii

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/guo6zxblnbgqffnmsupvlidyii

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3066648

1 reference

4 August 2017

1 reference